UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma

British journal of cancer, 2017-10, Vol.117 (9), p.1295-1302

2017

Volltextzugriff (PDF)

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

The Lancet (British edition), 2016-04, Vol.387 (10027), p.1551-1560

2016

Volltextzugriff (PDF)

P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS

HemaSphere, 2022-06, Vol.6 (Suppl), p.1043-1044

2022

Volltextzugriff (PDF)

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry

EJHaem, 2020-07, Vol.1 (1), p.188-198

2020

Volltextzugriff (PDF)

PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA IN THE MAGNIFY PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE

Hematology, Transfusion and Cell Therapy, 2021-10, Vol.43, p.S98-S98

2021

Volltextzugriff (PDF)

INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Hematology, Transfusion and Cell Therapy, 2021-10, Vol.43, p.S73-S73

2021

Volltextzugriff (PDF)

SUBGROUP ANALYSES OF ELDERLY PATIENTS AGED 70 YEARS IN MAGNIFY: A PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA

Hematology, Transfusion and Cell Therapy, 2021-10, Vol.43, p.S105-S106

2021

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumors

Clinical cancer research, 2007-10, Vol.13 (19), p.5876-5882

2007

Volltextzugriff (PDF)

Accelerated R-COP: A Pilot Study for the Treatment of Advanced Low Grade Lymphomas that Has a High Complete Response Rate

Journal of chemotherapy (Florence), 2009-08, Vol.21 (4), p.434-438

2009

Volltextzugriff (PDF)

INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY TRANSFORMED FOLLICULAR LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Costs Associated with Follicular Lymphoma Among Medicare Beneficiaries: An Incremental Cost Analysis

Value in health, 2018-05, Vol.21, p.S23

2018

Volltextzugriff (PDF)

PCN64 - Costs Associated with Follicular Lymphoma Among Medicare Beneficiaries: An Incremental Cost Analysis

Value in health, 2018-05, Vol.21, p.S23-S23

2018

Volltextzugriff (PDF)

PCN233 - Treatment Utilization Patterns Among Elderly Patients Diagnosed With Follicular Lymphoma In The United States Between 2000 And 2013

Value in health, 2018-05, Vol.21, p.S48-S48

2018

Volltextzugriff (PDF)

Treatment Utilization Patterns Among Elderly Patients Diagnosed With Follicular Lymphoma In The United States Between 2000 And 2013

Value in health, 2018-05, Vol.21, p.S48

2018

Volltextzugriff (PDF)

INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY TRANSFORMED FOLLICULAR LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Mitigating the Impact of Acute and Chronic Post-thoracotomy Pain

Journal of cardiothoracic and vascular anesthesia, 2014-08, Vol.28 (4), p.1048-1056

2014

Volltextzugriff (PDF)

A phase I study of busulfan consolidation/intensification therapy for patients with high risk acute myeloid leukemia (AML)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.6580-6580

2006

Volltextzugriff (PDF)

The Role of Radiofrequency Ablation for Sacroiliac Joint Pain: A Meta-Analysis

PM & R, 2010-09, Vol.2 (9), p.842-851

2010

Volltextzugriff (PDF)

Anti-tumor activity of partially HLA-matched irradiated blood mononuclear cells in patients with advanced malignancies

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2552-2552

2006

Volltextzugriff (PDF)

Phase I study of imatinib mesylate and gemcitabine in patients with refractory solid tumor malignancy

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.3100-3100

2005

Volltextzugriff (PDF)

Phase II trial of imatinib mesylate in patients with metastatic unresectable pancreatic cancer

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4183-4183

2005

Volltextzugriff (PDF)

Analgesic pipeline: Where are we headed?

Techniques in regional anesthesia & pain management, 2010-04, Vol.14 (2), p.41-41

2010

Volltextzugriff (PDF)

Epidural steroid injections: An update on mechanisms of injury and safety

Techniques in regional anesthesia & pain management, 2009-10, Vol.13 (4), p.266-271

2009

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(62)

Publikationsform

Artikel
(66)
Berichte
(1)

Sprache

Englisch
(67)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A phase I/II study of KW-2478, an Hsp90 inhibitor, in combination with bortezomib in patients with relapsed/refractory multiple myeloma

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

P1156: MAGNIFY PHASE 3B STUDY OF LENALIDOMIDE + RITUXIMAB (R2) FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON‐HODGKIN LYMPHOMA: COMPLETE INDUCTION PHASE ANALYSIS

Longitudinal health‐related quality of life in first‐line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL Registry

PATIENTS WITH RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA IN THE MAGNIFY PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE

INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

SUBGROUP ANALYSES OF ELDERLY PATIENTS AGED 70 YEARS IN MAGNIFY: A PHASE 3B INTERIM ANALYSIS OF INDUCTION R2 FOLLOWED BY MAINTENANCE IN RELAPSED/REFRACTORY INDOLENT NON-HODGKIN LYMPHOMA

Phase I and Pharmacokinetic Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumors

Accelerated R-COP: A Pilot Study for the Treatment of Advanced Low Grade Lymphomas that Has a High Complete Response Rate

INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY TRANSFORMED FOLLICULAR LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

INDUCTION R 2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Costs Associated with Follicular Lymphoma Among Medicare Beneficiaries: An Incremental Cost Analysis

PCN64 - Costs Associated with Follicular Lymphoma Among Medicare Beneficiaries: An Incremental Cost Analysis

PCN233 - Treatment Utilization Patterns Among Elderly Patients Diagnosed With Follicular Lymphoma In The United States Between 2000 And 2013

Treatment Utilization Patterns Among Elderly Patients Diagnosed With Follicular Lymphoma In The United States Between 2000 And 2013

INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

INDUCTION R2 FOLLOWED BY MAINTENANCE IN PATIENTS WITH RELAPSED/REFRACTORY TRANSFORMED FOLLICULAR LYMPHOMA: INTERIM ANALYSIS FROM THE PHASE 3B MAGNIFY STUDY

Mitigating the Impact of Acute and Chronic Post-thoracotomy Pain

A phase I study of busulfan consolidation/intensification therapy for patients with high risk acute myeloid leukemia (AML)

The Role of Radiofrequency Ablation for Sacroiliac Joint Pain: A Meta-Analysis

Anti-tumor activity of partially HLA-matched irradiated blood mononuclear cells in patients with advanced malignancies

Phase I study of imatinib mesylate and gemcitabine in patients with refractory solid tumor malignancy

Phase II trial of imatinib mesylate in patients with metastatic unresectable pancreatic cancer

Analgesic pipeline: Where are we headed?

Epidural steroid injections: An update on mechanisms of injury and safety

Suchergebnisse filtern